Mynvax
Bangalore
About Mynvax
Mynvax is an Indian-based biotech startup that develops next-generation vaccines for influenza. In addition, the technology allows for very rapid, large-scale, and low-cost production of vaccines that could potentially be used to protect people when there is a pandemic. Mynvax, which was incubated at the Indian Institute of Science, was founded in 2017 by Raghavan Varadarajan and Gautham Nadig.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $100K – $500K
- Total funding: $6.7M
- Funding stage: Early Stage Venture
- Last round: Series A (May 2024)
- Website: mynvax.com
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/mynvax-18290 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.